Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients - A commentary on "The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?" [Int. J. Surg. 100 (Suppl) (2022) 106492)].

MohanaSundaram, ArunSundar; Thukani Sathanantham, Shanmugarajan; Velayutham, Ravichandiran

MohanaSundaram, ArunSundar; Thukani Sathanantham, Shanmugarajan; Velayutham, Ravichandiran.

MohanaSundaram A; School of Pharmacy, Sathyabama Institute of Science and Technology, Chennai, Tamilnadu, India. Electronic address: arunsundar.pharmacy@sathyabama.ac.in.
Thukani Sathanantham S; School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Chennai, Tamilnadu, India. Electronic address: shanmuga5@yahoo.com.
Velayutham R; National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, India. Electronic address: directorniperkolkata@gmail.com.

Int J Surg ; 105: 106823, 2022 09.

Article in English | MEDLINE | ID: covidwho-1996278

Subject(s)

COVID-19; Liver Transplantation; Vaccines; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Liver Transplantation/adverse effects; Transplant Recipients

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Liver Transplantation / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Int J Surg Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google